From Drugs Prescribing Information
Jump to: navigation, search
Click on "►" to expand:






Cefadroxil is a first-generation cephalosporin.

Like all beta-lactam antibiotics, cefadroxil binds to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, causing the inhibition of the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins


Cefadroxil is indicated for the treatment of the following infections when caused by susceptible strains of the designated microorganisms:

  • Urinary tract infections caused by E. coli,P. mirabilis, and Klebsiella species.
  • Skin and skin structure infections caused by staphylococci and/or streptococci.
  • Pharyngitis and tonsillitis caused by group A beta-hemolytic streptococci. (Penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. Cefadroxil is generally effective in the eradication of streptococci from the nasopharynx; however, substantial data establishing the efficacy of Cefadroxil in the subsequent prevention of rheumatic fever are not available at present.)

“Culture and susceptibility tests should be initiated prior to and during therapy. Renal function studies should be performed when indicated.”

[edit] DOSAGE

Cefadroxil is acid stable and may be administered orally without regard to meals. Administration with food may be helpful in diminishing potential gastrointestinal complaints occasionally associated with oral cephalosporin therapy.


Urinary Tract Infections
For uncomplicated lower urinary tract infections (i.e., cystitis) the usual dosage is 1 or 2 grams per day in single (qd) or divided doses (bid).

For all other urinary tract infections, the usual dosage is 2 grams per day in divided doses (bid).

Skin and Skin Structure Infections
For skin and skin structure infections, the usual dosage is 1 gram per day in single (qd) or divided doses (bid).

Pharyngitis and Tonsillitis
Treatment of group A beta-hemolytic streptococcal pharyngitis and tonsillitis - 1 gram per day in single (qd) or divided doses (bid) for 10 days.


Urinary tract infections and for skin and skin structure infections
The recommended daily dosage is 30 mg/kg/day in divided doses every 12 hours.

Pharyngitis and tonsillitis
The recommended daily dosage is 30 mg/kg/day in single (qd) or divided doses (bid). In the treatment of beta-hemolytic streptococcal infections, a therapeutic dosage of Cefadroxil should be administered for at least 10 days.

Patients with renal impairment
The dosage of Cefadroxil monohydrate should be adjusted according to creatinine clearance rates to prevent drug accumulation.

Patients with creatinine clearance rates over 50 ml/min may be treated as if they were patients having normal renal function.


Cefadroxil is contraindicated in patients with known allergy to the cephalosporin group of antibiotics.



In penicillin-allergic patients, cephalosporin antibiotics should be used with great caution. There is clinical and laboratory evidence of partial cross-allergenicity of the penicillins and the cephalosporins, and there are instances of patients who have had reactions to both drugs (including fatal anaphylaxis after parenteral use).

Any patient who has demonstrated a history of some form of allergy, particularly to drugs, should receive antibiotics cautiously and then only when necessary. No exception should be made with regard to Cefadroxil.

Pseudomembranous colitis has been reported with the use of cephalosporins (and other broad-spectrum antibiotics); therefore, it is important to consider its diagnosis in patients who develop diarrhea in association with antibiotic use.

Treatment with broad-spectrum antibiotics alters normal flora of the colon and may permit overgrowth of clostridia. Studies indicate a toxin produced by Clostridium difficile is one primary cause of antibiotic-associated colitis. Cholestyramine and colestipol resins have been shown to bind the toxin in vitro.

Mild cases of colitis may respond to drug discontinuance alone. Moderate to severe cases should he managed with fluid, electrolyte, and protein supplementation as indicated.

When the colitis is not relieved by drug discontinuance or when it is severe, oral vancomycin is the treatment of choice for antibiotic-associated pseudomembranous colitis produced by C. difficile. Other causes of colitis should also be considered.


Patients should be followed carefully so that any side effects or unusual manifestations of drug idiosyncrasy may be detected. If a hypersensitivity reaction occurs, the drug should be discontinued and the patient treated with the usual agents (eg. epinephrine, or other pressor amines, antihistamines, or corticosteroids).

Cefadroxil should be used with caution in the presence of markedly impaired renal function (creatinine clearance rate of less than 50 ml/ min/1.73 M2).

In patients, with known or suspected renal impairment, careful clinical observation and appropriate laboratory studies should be made prior to and during therapy.

Prolonged use of Cefadroxil may result in the overgrowth of nonsusceptible organisms. Careful observation of the patient is essential. If super infection occurs during therapy, appropriate measures should be taken.

Positive direct Coombs' tests have been reported during treatment with the cephalosporin antibiotics. In hematologic studies or in transfusion cross-matching procedures when antiglobulin tests are performed on the minor side orin Coombs' testing of newborns whose mothers have received cephalosporin antibiotics before parturition, it should be recognized that a positive Coombs' test may be due to the drug.

Cefadroxil should be prescribed with caution in individuals with a history of gastrointestinal disease, particularly colitis.



Pregnancy Category B (US): There are no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.

Nursing Mothers
Caution should be exercised when Cefadroxil is administered to anursing mother.


Symptoms of pseudomembranous colitis can appear during antibiotic treatment. Nausea and vomiting have been reported rarely. Diarrhea and dysuria have also occurred.

Allergies (in the form of rash, urticaria, and angioedema) have been observed. These reactions usually subsided upon discontinuation of the drug.

Other reactions have included genital pruritus, genital moniliasis, vaginitis, moderate transient neutropenia, and minor elevations in serum transaminase. Stevens-Johnson syndrome has been rarely reported.